Notice Number: NOT-AI-20-040
Key Dates
Release Date: March 25, 2020
Issued by
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of General Medical Sciences (NIGMS)
Purpose
The purpose of this Notice is to inform the extramural community that NOT-AI-20-030, “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)” will be rescinded as of 04/08/2020 . NOT-AI-20-030 will be replaced by NOT-AI-20-034 for NIAID competitive revisions and NOT-GM-20-025 for NIGMS competitive revisions.
NIAID will replace NOT-AI-20-030 with NOT-AI-20-034 which uses a different funding opportunity announcement, PA-20-135, “Emergency Competitive Revision to Existing NIH Awards (Clinical Trial Optional)” for competitive revision application submissions in response to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) outbreak. NIAID applicants will have the option of applying to either NOT-AI-20-030 or NOT-AI-20-034 up until 04/08/2020 but are strongly encouraged to transition their application to NOT-AI-20-034 using the PA-20-135, “Emergency Competitive Revision to Existing NIH Awards (Clinical Trial Optional)” as soon as possible. However, NIAID will only accept applications to NOT-AI-20-034 after 04/08/2020. NIGMS will issue a new NOSI that will continue to use PA-18-935.
NIGMS will replace NOT-AI-20-030 with NOT-GM-20-025 which will continue to receive competitive revision applications to PA-18-935 “Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)”. NIGMS’s new Notice includes additional areas of interest related to SARS-CoV-2 and COVID-19 and will allow support of competitive revisions above the established dollar limits for the parent grant award. Please see NOT-GM-20-025 for more information. NIGMS applicants will have the option of applying to either NOT-AI-20-030 or NOT-GM-20-025 up until 04/08/2020 but are strongly encouraged to transition their application to NOT-GM-20-025 as soon as possible.
Inquiries
Please direct all inquiries to:
Diane Post, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3348
Email: postd@niaid.nih.gov
Daniel E. Janes, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: daniel.janes@nih.gov